• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of atrial fibrillation burden in assessing thromboembolic risk.

作者信息

Zimetbaum Peter, Waks Jonathan W, Ellis Ethan R, Glotzer Taya V, Passman Rod S

机构信息

From the Department of Cardiovascular Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (P.Z., J.W.W., E.R.E.); Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, IL (R.S.P.); and Division of Cardiology, Hackensack University Medical Center, NJ (T.V.G.).

出版信息

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1223-9. doi: 10.1161/CIRCEP.114.001356.

DOI:10.1161/CIRCEP.114.001356
PMID:25516580
Abstract
摘要

相似文献

1
Role of atrial fibrillation burden in assessing thromboembolic risk.心房颤动负荷在评估血栓栓塞风险中的作用。
Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1223-9. doi: 10.1161/CIRCEP.114.001356.
2
[Anticoagulation in atrial fibrillation. Strategies in special situations].[心房颤动的抗凝治疗。特殊情况下的策略]
Clin Res Cardiol Suppl. 2011 May;6:58-65. doi: 10.1007/s11789-011-0022-6.
3
Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.正方观点：“华法林应该是老年房颤患者血栓预防的首选药物”。为什么华法林确实应该成为老年房颤患者预防中风的首选药物。
Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344.
4
Is the risk of stroke in permanent and paroxysmal atrial fibrillation really the same? Therein lies the dilemma.永久性和阵发性心房颤动的中风风险真的一样吗？这就是问题所在。
J Cardiovasc Med (Hagerstown). 2020 Aug;21(8):540-546. doi: 10.2459/JCM.0000000000000977.
5
Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.心房颤动合并慢性肾脏病患者的抗凝治疗：疗效与安全性。
Expert Opin Drug Saf. 2013 Jan;12(1):53-63. doi: 10.1517/14740338.2013.732569. Epub 2012 Oct 24.
6
Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.阵发性心房颤动、中风风险与血栓预防
Thromb Haemost. 2008 Jul;100(1):11-3. doi: 10.1160/TH08-05-0331.
7
Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation.新型口服抗凝药用于预防心房颤动患者的血栓栓塞。
J R Coll Physicians Edinb. 2013;43(2):151-8. doi: 10.4997/JRCPE.2013.213.
8
Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.反对观点：“华法林应是老年房颤患者血栓预防的首选药物”。关于老年房颤患者使用口服抗凝治疗的注意事项。
Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343.
9
[Anticoagulation in atrial fibrillation].[心房颤动的抗凝治疗]
Herz. 2008 Feb;33(1):13-9. doi: 10.1007/s00059-008-3090-8.
10
[Thromboembolic risk in atrial fibrillation: new clinical perspectives].[心房颤动中的血栓栓塞风险：新的临床视角]
G Ital Cardiol (Rome). 2008 Oct;9(10 Suppl 1):22S-26S.

引用本文的文献

1
Post-Ischemic Stroke Cardiovascular Risk Prevention and Management.缺血性中风后心血管风险的预防与管理
Healthcare (Basel). 2024 Jul 16;12(14):1415. doi: 10.3390/healthcare12141415.
2
COVID-19 HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research.COVID-19引发的心脏问题表现为心房颤动：病理生理学、管理及未来研究方向
Egypt Heart J. 2023 Apr 30;75(1):36. doi: 10.1186/s43044-023-00359-0.
3
Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation.
个体化抗凝治疗以降低阵发性心房颤动的血栓栓塞风险
J Innov Card Rhythm Manag. 2018 Apr 15;9(4):3116-3125. doi: 10.19102/icrm.2018.090404. eCollection 2018 Apr.
4
Intermittent vs. Continuous Anticoagulation theRapy in patiEnts with Atrial Fibrillation (iCARE-AF): a randomized pilot study.心房颤动患者间歇性与持续性抗凝治疗（iCARE-AF）：一项随机试点研究
J Interv Card Electrophysiol. 2017 Jan;48(1):51-60. doi: 10.1007/s10840-016-0192-8. Epub 2016 Oct 1.
5
Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research: National Heart, Lung, and Blood Institute Working Group.用于精准心血管护理和临床研究的即时检测技术：美国国立心肺血液研究所工作组
JACC Basic Transl Sci. 2016 Jan-Feb;1(1-2):73-86. doi: 10.1016/j.jacbts.2016.01.008.
6
Simulation of Daily Snapshot Rhythm Monitoring to Identify Atrial Fibrillation in Continuously Monitored Patients with Stroke Risk Factors.模拟每日快照节律监测以识别持续监测的有中风危险因素患者的房颤
PLoS One. 2016 Feb 16;11(2):e0148914. doi: 10.1371/journal.pone.0148914. eCollection 2016.
7
Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model.心房颤动与卒中机制：建立新模型的时候了。
Stroke. 2016 Mar;47(3):895-900. doi: 10.1161/STROKEAHA.115.012004. Epub 2016 Jan 19.
8
Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study.血液透析患者的心律失常与猝死：透析研究中监测的方案及基线特征
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):721-34. doi: 10.2215/CJN.09350915. Epub 2016 Jan 13.